Abstract
The development of a potent mechanism-based inactivator of NagZ, an enzyme critical to the production of inducible AmpC β-lactamase in Gram-negative bacteria, is presented. This inactivator significantly reduces MIC values for important β-lactams against a clinically relevant strain of Pseudomonas aeruginosa.
MeSH terms
-
Acetylglucosaminidase / antagonists & inhibitors*
-
Acetylglucosaminidase / metabolism
-
Anti-Bacterial Agents / chemical synthesis
-
Anti-Bacterial Agents / metabolism
-
Anti-Bacterial Agents / pharmacology*
-
Aztreonam / pharmacology
-
Bacterial Proteins / antagonists & inhibitors*
-
Bacterial Proteins / metabolism
-
Burkholderia cenocepacia / enzymology
-
Ceftazidime / pharmacology
-
Enzyme Inhibitors / chemical synthesis
-
Enzyme Inhibitors / metabolism
-
Enzyme Inhibitors / pharmacology*
-
Epoxy Compounds / chemical synthesis
-
Epoxy Compounds / metabolism
-
Epoxy Compounds / pharmacology*
-
Humans
-
Imipenem / pharmacology
-
Microbial Sensitivity Tests
-
Protein Binding
-
Pseudomonas aeruginosa / enzymology
-
Pseudomonas aeruginosa / metabolism*
-
beta-Lactam Resistance / drug effects*
-
beta-N-Acetylhexosaminidases / antagonists & inhibitors
Substances
-
Anti-Bacterial Agents
-
Bacterial Proteins
-
Enzyme Inhibitors
-
Epoxy Compounds
-
Imipenem
-
Ceftazidime
-
alpha-N-acetyl-D-glucosaminidase
-
hexosaminidase C
-
Acetylglucosaminidase
-
beta-N-Acetylhexosaminidases
-
Aztreonam